PositiveID Featured in Government Security News and Homeland Security Today
January 28 2014 - 8:30AM
PositiveID Corporation ("PositiveID" or "Company") (OTCQB:PSID), a
developer of biological detection and diagnostics solutions, today
announced that its homeland security and medical diagnostics
products, M-BAND and Firefly, are featured in Government Security
News and Homeland Security Today.
PositiveID's M-BAND (Microfluidic Bio-agent Autonomous Networked
Detector) continuously and autonomously analyzes air samples for
the detection of biological airborne threats in the form of
bacteria, viruses, and toxins. The technology was developed under
contract with the U.S. Department of Homeland Security ("DHS")
Science & Technology directorate, which included $30 million of
contract funding. M-BAND is positioned to capitalize on the next
generation of BioWatch, which is the U.S. government's $3-$5
billion program to detect the release of pathogens into the air as
part of a defense against potential terrorist attacks on major
American cities.
The Company's Firefly Dx is a point-of-need, handheld system
designed to deliver molecular diagnostic results using real-time
TaqMan® PCR (polymerase chain reaction) chemistry. Firefly is being
developed to meet the growing need in healthcare and molecular
diagnostics markets for more rapid and accurate point-of-need
diagnostics that will enable hospitals, physicians and other
providers to save lives. Firefly can derive results from a sample
in less than 20 minutes, at the point of need, compared to two to
four hours for a lab device, which would enable accurate
diagnostics leading to more rapid and effective treatment than what
is currently available with existing systems.
William J. Caragol, Chairman and CEO of PositiveID, stated, "We
are actively engaged with our strategic partners and homeland
security officials at the federal, state and local levels to bring
our products to market to help protect our nation from
bio-terrorism and other medical emergencies."
Last week, PositiveID published a report on the market
opportunities for M-BAND and Firefly. A copy of the report is
available on PositiveID's website at
http://www.positiveidcorp.com/files/PositiveID_Market_Opportunities_2014-01-24.pdf.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and
developer of biological detection systems for America's homeland
defense industry as well as rapid biological testing. PositiveID is
focused on the development of microfluidic systems for the
automated preparation of and performance of biological assays in
order to detect biological threats at high-value locations, as well
as analyze samples in a medical environment. For more information
on PositiveID, please visit http://www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including,
without limitation, the likelihood that M-BAND is positioned to
capitalize on the next generation of BioWatch; the likelihood that
Firefly is being developed to meet the growing need in healthcare
and molecular diagnostics markets for more rapid and accurate
point-of-need diagnostics that will enable hospitals, physicians
and other providers to save lives; the likelihood that Firefly
would enable accurate diagnostics leading to more rapid and
effective treatment than what is currently available with existing
systems; and all statements in this press release constitute
"forward-looking statements" within the meaning of Section 27A of
the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Litigation
Reform Act of 1995. Such forward-looking statements involve risks
and uncertainties and are subject to change at any time, and
PositiveID's actual results could differ materially from expected
results. These risks and uncertainties include, without limitation,
the Company's ability to target the bio-threat detection and rapid
medical testing sectors; as well as other risks. Additional
information about these and other factors that could affect the
Company's business is set forth in the Company's various filings
with the Securities and Exchange Commission, including those set
forth in the Company's 10-K filed on April 16, 2013, and 10-Qs
filed on May 20, 2013, August 14, 2013, as amended August 19, 2013,
and November 19, 2013, under the caption "Risk Factors." The
Company undertakes no obligation to update or release any revisions
to these forward-looking statements to reflect events or
circumstances after the date of this statement or to reflect the
occurrence of unanticipated events, except as required by law.
CONTACT: PositiveID Corporation
Allison Tomek
561-805-8000
atomek@positiveidcorp.com